Topic Hub
19 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 19 of 19 clinical reviews.
Board-reviewed analysis of combining Repatha (evolocumab) with acetaminophen. Covers CYP metabolism, hepatic safety, monitoring recommendations, and dose guidance.
Read clinical reviewClinical review of the evolocumab (Repatha) and apixaban drug interaction, covering pharmacokinetic mechanisms, safety data, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewBoard-reviewed analysis of whether Repatha (evolocumab) interacts with benzodiazepines. Covers pharmacokinetic and pharmacodynamic mechanisms, FDA label data, monitoring recommendations, and patient counseling points.
Read clinical reviewClinical analysis of the interaction profile between Repatha (evolocumab) and finasteride. Covers pharmacokinetic and pharmacodynamic data, monitoring recommendations, and prescriber guidance.
Read clinical reviewClinical review of evolocumab (Repatha) and hormonal contraceptive interactions, covering pharmacokinetic mechanisms, safety data, and monitoring recommendations.
Read clinical reviewIs there a drug interaction between Repatha (evolocumab) and levothyroxine? Review the pharmacokinetic and pharmacodynamic evidence, FDA labeling, and clinical guidance for safe co-administration.
Read clinical reviewIs it safe to take Repatha (evolocumab) with metformin? A physician-reviewed guide covering pharmacokinetics, clinical trial data, monitoring recommendations, and real-world co-prescribing evidence.
Read clinical reviewClinical analysis of whether Repatha (evolocumab) interacts with opioids like oxycodone, hydrocodone, and tramadol. Mechanism review, safety data, and monitoring guidance.
Read clinical reviewClinical review of the evolocumab and prednisone drug interaction, covering pharmacokinetic and pharmacodynamic considerations, lipid effects, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewCan you take Repatha and pregabalin together? A physician-reviewed guide covering pharmacokinetic and pharmacodynamic profiles, DDI databases, monitoring recommendations, and dose-adjustment protocols for evolocumab plus pregabalin.
Read clinical reviewBoard-reviewed analysis of the Repatha (evolocumab) and sildenafil drug interaction. Covers pharmacokinetics, pharmacodynamics, clinical evidence, and monitoring recommendations.
Read clinical reviewIs it safe to take Repatha (evolocumab) with bupropion? A detailed clinical guide covering mechanism, risk severity, monitoring parameters, and dose adjustments for this drug combination.
Read clinical reviewIs it safe to take Repatha (evolocumab) with clopidogrel? A detailed look at the pharmacokinetic and pharmacodynamic interaction profile, clinical trial evidence, monitoring recommendations, and patient counseling points.
Read clinical reviewA clinical deep-dive into whether evolocumab (Repatha) interacts with proton pump inhibitors like omeprazole or pantoprazole, covering mechanism, safety data, monitoring, and patient counseling.
Read clinical reviewCan you take Repatha (evolocumab) with simvastatin? A physician-reviewed guide covering the pharmacologic interaction, clinical trial data, monitoring protocols, and dose considerations.
Read clinical reviewCan you take Repatha (evolocumab) with testosterone? A clinician-reviewed guide to the pharmacodynamic interaction, lipid monitoring, polycythemia risk, and dose-adjustment considerations.
Read clinical reviewA detailed, physician-reviewed guide to the evolocumab (Repatha) and trazodone drug interaction, covering mechanism, severity, monitoring, dose considerations, and patient counseling.
Read clinical reviewIs it safe to take Repatha (evolocumab) with warfarin? A clinical review of the pharmacokinetic and pharmacodynamic evidence, monitoring protocols, and practical prescribing guidance.
Read clinical reviewIs it safe to take Repatha (evolocumab) with zolpidem? A physician-reviewed analysis of pharmacokinetic and pharmacodynamic interaction data, monitoring recommendations, and dose-adjustment guidance.
Read clinical review